TABLE OF CONTENTS
Contents
pages
Title page
i
Certification ii
Dedication iii
Acknowledgements iv
Table of Contents v
Abstract vi
CHAPTER
ONE
1.0 Introduction 1
1.1 Background Study 1
1.2 Statement of the problem 2
1.3 Justification 3
1.4 Aim and Objectives of Study 4
CHAPTER
TWO
2.0 Literature review 6
2.1 Definition and history of Malaria 6
2.1.2 Etiologic and vectors of malaria 7
2.1.3 Epidermiology of malaria 8
2.1.4 Life cycle of malaria
parasite 10-13
2.1.5Molecular
cell biology and pathogenesis 13
2.1.6Diagnosis of malaria 14
2.1.7 Management of malaria 18
2.1.7.1Conventional therapeutic agents 18
2.1.7.2 Drug in pipeline 19
2.2 Traditional medicine 21
2.2.1 Control measures 22
2.3 Malaria vaccine 24
2.4 The experimental plant 25
2.4.1Moringa Oleifera 26
2.4.2 Social Economic importance of
morning oleifera 29
2.4.3 Ecology and Cultivation 29
CHAPTER
THREE
3.0 Collection of plant 42
3 .1 Control drugs 42
3.2 Experimental animal 43
3.3 Materials and reagent 43
3.4 Extraction from the plant
seed 43
3.5 Gas chromatography mass
spectrometry 44
3.6. Experimental Design 50
3.7 Collection and inoculation
of the parasite 50
3.8 Statistical Analysis 52
3.9 Presentation and
statistical analysis of Data 52
CHAPTER FOUR
4.0 Result
53
4.1 Parasite density at different
concentration of the extract of Maringa oliefera seed 55
4.2 Percentage difference in parasitaemia
inhibition at different concentration among
seed 58
CHAPTER
FIVE
5.0 Discussion 60
5.1 Conclusion 61
5.2
Recommendation 62
ABSTRACT
Malaria
is an increasing worldwide threat, with more than three hundred million
infections and one million deaths every year. Due to the emergence of
antimalarial drug resistance, the continuous search for antimalarial agents.
This study was conducted to determine the antimalarial efficacy of Moringa
oleifera Seed extract in Swiss albino mice infected with Plasmodium berghei
.After extraction, phytochemical screening and gas chromatographic mass
spectrometry (GC-MS) screening of the extract, the mice were grouped into six
groups, five
per group. Designated as 40% treated
with 40mg/kg of the Maringa oliefera seed extract, 60% treated with 60mg/kg,
80% treated with 80mg/kg,100% treated with 100mg/kg and positive control
treated with distilled water while negative control was given
choloroquone. For the period of 3 days
at 12 hours interval. Parasite density
was determine by preparing of thick and thin blood film, stain with Giemsa stain
and view under microscope to determine
the antiplamodial activity of the extract
CHAPTER ONE
1.0 INTRODUCTION
1.1 Background of the
study
Since the beginning of human civilization,
medicinal plants have been used by mankind for its therapeutic value. Nature
has been a source of medicinal agents for thousands of years and an impressive
number of modern drugs have been isolated from natural sources. Many of these
isolations were based on the uses of the agents in traditional medicine. The
plant-based, traditional medicine systems continues to play an essential role
in health care, with about 80% of the world’s inhabitants relying mainly on traditional
medicines for their primary health care (Owolabi et al., 2007).
Medicinal plants are plants containing inherent active ingredients used to cure
disease or relieve pain (Okigbo et al., 2008). The medicinal properties
of plants could be based on the antioxidant, antimicrobial antipyretic effects
of the phytochemicals in them (Cowman, 1999; Adesokan et al., 2008). The
ancient texts like Rig Veda (4500-1600 BC) and Atharva Veda mention the use of
several plants as medicine. The books on ayurvedic medicine such as Charaka
Samhita and Susruta Samhita refer to the use of more than 700 herbs
(Jain, 1968). According to the World Health Organization (WHO, 1977) “a
medicinal plant” is any plant, which in one or more of its organ contains
substances that can be used for the therapeutic purposes (Okigbo, 2009). The
term “herbal drug” determines the part/parts of a plant (leaves, flowers, seed,
roots, barks, stems, etc.) used for preparing medicines.
1.2 Statement of the
problem
Malaria
is a potentially deadly parasitic disease of global public health relevance.
The infection is known to cause death and illness in children and adults,
especially in tropical countries. In Nigeria, malaria is termed to be endemic
and perennial in all parts, with seasonal variations more pronounced in the
Northern part (Caraballo, 2014). According to
the 2010 national census, 24.2 million Ghanaians are at risk of malaria
infection. Children under five years and pregnant women however stand a higher
risk of severe illness due to declined immunity (WHO,
2014). The control
of malaria requires an integrated approach, including prevention, which deals
primarily with vector control and prompt treatment with effective anti-malarial
(WHO, 2014).
Management
of malaria has seen a lot of changes, mainly as a result of resistance
development of P. falciparum against anti-malarials in use. For
instance, Chloroquine, which used to be one of the most effective drugs, has
now been proven to be ineffective in malaria treatment (Greenwood
et al., 2010). Currently, WHO recommends a
combination therapy involving any of the artemisinins and other classes of
antimalarials for the treatment of uncomplicated malaria (WHO,
2014).
Some of the recommended
combinations include, Artesunate -Amodiaquine, Artemether - Lumefantrine,
Atovaquone-Proguanil, Chloroquine-Proguanil, and Mefloquine–
Sulphadoxine-Pyrimethamine (CDC, 2016).
A school of thought holds
that, the solution to plasmodial resistance development rests in the use of
traditional medicinal plants (Liu et al., 2010). Several authors have
documented medicinal plants that are used in the treatment of malaria in Ghana
and other African countries (Cox, 2010). The story behind the
discovery of the artemisinins, as an example, seeks to provide a head way in
the discovery of bioactive constituents from medicinal plants for combating
malaria (Cox, 2010). Armed with information from successful traditional
treatments of malaria, it is possible to discover novel compounds from plants
that could be developed into potent antimalarials. This study was thus carried
out to determine the antiplasmodium activities of extract from the seed of Moringa
oleifera Lam (Moringaceae).
1.3 Justification of the
study
In
sub-Saharan Africa, infectious diseases remain the predominant cause of illness
and death. Plasmodium falciparum malaria alone causes an estimated 1
million deaths annually (Lopez et al.,
2009). Malaria remains the most serious and widespread
protozoal infection of humans. Over 40% of the
world’s population is at risk of contracting malaria,
which is endemic in 91 countries, mostly developing. The disease is
widespread in tropical
and subtropical
regions that are present in a broad band around the equator,
(Caraballo, 2014). This includes much of Sub-Saharan Africa, Asia, and Latin America.
The World Health Organization estimates that
in 2012, there were 207 million cases of malaria. That year, the disease is
estimated to have killed between 473,000 and 789,000 people, many of whom were
children in Africa, (WHO, 2014). Malaria is commonly associated with poverty
and has a major negative effect on economic development, (Worrall et al., 2009).
In Africa it is estimated to result in losses of $12 billion USD a year due to
increased healthcare costs, lost ability to work and effects on tourism, (Greenwood
et al., 2010).
However drug resistance to malaria has been a major challenge to public health.
Many authors have documented drug resistance strains of plasmodium falciparun (WHO, 2010). However many countries such as
Mali, China, Vietnam, Sri Lanka and India has integrated herbal products into
their health care delivery system for effective treatment (Kazambe and
Munyarari, 2006). But in Nigeria, natural products is yet to gain wider
acceptance by the physicians due to the facts that most natural products does
not have a biochemical explanation to their mode of action. Also there is
paucity of information on the anti-plasmodium properties of Moringa Oleifera seed extracts, against
the background this study was carried out.
1.4 Aim and objectives
1.4.1 Aim of the study
This
study aims at investigating the ligands and in-vivo anti-plasmodium study of Moringa Oleifera seed extract.
1.4.2 Specific objectives
The
specific objectives of this study where:
·
To assess the
phytochemical components of the extracts from the seed of Moringa Oleifera
·
To investigate the
in-vivo anti-plasmodium activities of extracts from Moringa Oleifera seedon on laboratory animals at different concentration
·
To evaluate the percentage parasitaemia inhibition
at different concentration among Moringa olifera seed extract administration
Research Hypothesis
(Null)
Ho: Extracts from the seed of Moringa Oleifera does
not contain ligands
Ho: Extracts
from the seed of Moringa Oleifera does
not contain phytochemical components
Ho: Extracts from the seed of Moringa Oleifera shows
no significant difference in percentage
parasitaemia inhibiton.
Click “DOWNLOAD NOW” below to get the complete Projects
FOR QUICK HELP CHAT WITH US NOW!
+(234) 0814 780 1594
Buyers has the right to create
dispute within seven (7) days of purchase for 100% refund request when
you experience issue with the file received.
Dispute can only be created when
you receive a corrupt file, a wrong file or irregularities in the table of
contents and content of the file you received.
ProjectShelve.com shall either
provide the appropriate file within 48hrs or
send refund excluding your bank transaction charges. Term and
Conditions are applied.
Buyers are expected to confirm
that the material you are paying for is available on our website
ProjectShelve.com and you have selected the right material, you have also gone
through the preliminary pages and it interests you before payment. DO NOT MAKE
BANK PAYMENT IF YOUR TOPIC IS NOT ON THE WEBSITE.
In case of payment for a
material not available on ProjectShelve.com, the management of
ProjectShelve.com has the right to keep your money until you send a topic that
is available on our website within 48 hours.
You cannot change topic after
receiving material of the topic you ordered and paid for.
Login To Comment